1. Home
  2. DBVT vs SRI Comparison

DBVT vs SRI Comparison

Compare DBVT & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • SRI
  • Stock Information
  • Founded
  • DBVT 2002
  • SRI 1965
  • Country
  • DBVT France
  • SRI United States
  • Employees
  • DBVT N/A
  • SRI N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • SRI Auto Parts:O.E.M.
  • Sector
  • DBVT Health Care
  • SRI Consumer Discretionary
  • Exchange
  • DBVT Nasdaq
  • SRI Nasdaq
  • Market Cap
  • DBVT 102.0M
  • SRI 106.8M
  • IPO Year
  • DBVT N/A
  • SRI 1997
  • Fundamental
  • Price
  • DBVT $9.84
  • SRI $4.45
  • Analyst Decision
  • DBVT Strong Buy
  • SRI Buy
  • Analyst Count
  • DBVT 3
  • SRI 2
  • Target Price
  • DBVT $13.67
  • SRI $16.00
  • AVG Volume (30 Days)
  • DBVT 81.5K
  • SRI 267.6K
  • Earning Date
  • DBVT 04-30-2025
  • SRI 04-30-2025
  • Dividend Yield
  • DBVT N/A
  • SRI N/A
  • EPS Growth
  • DBVT N/A
  • SRI N/A
  • EPS
  • DBVT N/A
  • SRI N/A
  • Revenue
  • DBVT $3,497,000.00
  • SRI $887,028,000.00
  • Revenue This Year
  • DBVT $1,700.53
  • SRI N/A
  • Revenue Next Year
  • DBVT $535.67
  • SRI $10.21
  • P/E Ratio
  • DBVT N/A
  • SRI N/A
  • Revenue Growth
  • DBVT N/A
  • SRI N/A
  • 52 Week Low
  • DBVT $0.44
  • SRI $3.54
  • 52 Week High
  • DBVT $9.90
  • SRI $18.40
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 68.41
  • SRI 57.28
  • Support Level
  • DBVT $8.59
  • SRI $4.16
  • Resistance Level
  • DBVT $9.90
  • SRI $4.63
  • Average True Range (ATR)
  • DBVT 0.77
  • SRI 0.32
  • MACD
  • DBVT -0.02
  • SRI 0.11
  • Stochastic Oscillator
  • DBVT 91.04
  • SRI 59.93

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. Stoneridge generates the majority of its revenue in its Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Geographically, the company's operations are focused on North America. It has Control Devices, Electronics, and Stoneridge Brazil segments.

Share on Social Networks: